All COVID-19 articles
-
NewsBooster jabs reduce the risks of COVID-19 deaths, study finds
Booster vaccines reduced the risk of COVID‑19–related hospitalisation and death, according to a new study of over 3 million adults who had the autumn 2022 vaccine in England.
-
NewsCOVID-19 vaccination during pregnancy may help prevent preeclampsia
A new multinational study has found that COVID-19 vaccination during pregnancy, particularly when combined with a booster dose, significantly reduces the risk of preeclampsia, a serious and potentially life-threatening pregnancy complication.
-
NewsChildren with sleep apnea face higher risk of flu and COVID-19, new study finds
A five-year study has revealed that children with sleep apnea are twice as likely to contract the flu or COVID-19, regardless of their age or weight. Even after undergoing surgery to remove tonsils or adenoids, this increased vulnerability persists due to long-term changes in the immune system.
-
CareersSummer Studentship: novel antivirals and host-virus interactions
Jessica Harris reports back on her Summer Studentship at De Montfort University, and her research into how plant-derived compounds affect viruses, and whether combining these antivirals might increase viral inhibition.
-
NewsNo association between mRNA COVID-19 vaccination during pregnancy and autism in children, new research shows
The mRNA COVID-19 vaccine is not associated with autism or other neurodevelopmental problems in children whose mothers received the vaccine immediately before or during pregnancy, according to new research.
-
NewsLong COVID linked to Alzheimer’s disease mechanisms
The increased size of, and lesser blood supply to, a key brain structure in patients with Long COVID tracks with known blood markers of Alzheimer’s disease and greater levels of dementia, a new study finds.
-
NewsDiscovery of SARS-CoV-2 PLpro inhibitors and RIPK1 inhibitors with synergistic antiviral efficacy in a mouse COVID-19 model
A new article publication discusses the discovery of SARS-CoV-2 PLpro inhibitors and RIPK1 inhibitors with synergistic antiviral efficacy in a mouse COVID-19 model.
-
NewsStudy reveals dual forces driving SARS-CoV-2 evolution: Immune pressure and viral fitness
New research clarifies the complex role of neutralizing antibodies in shaping disease outcomes and the evolution of SARS-CoV-2.
-
NewsWhy aren’t more older adults getting flu or COVID-19 shots?
This winter’s brutal flu season isn’t over, and COVID-19 cases have risen recently too. But a new poll taken in recent weeks shows that vaccination against both viruses lags among people 50 and over, and the US survey reveals key reasons why.
-
NewsSix years after COVID-19’s global alarm: Is the world better prepared for the next pandemic?
Six years ago, the Director-General of the World Health Organization sounded the highest global alarm available under international law at the time, declaring the outbreak of a new coronavirus disease. As we cross this six-year mark, WHO asks: Is the world better prepared for the next pandemic?
-
NewsMetformin shown to prevent Long COVID across risk groups in multiple randomized trials
Multiple randomized clinical trials and electronic health record studies now show that metformin, a widely used and well-established medication, significantly reduces the risk of developing Long COVID when taken during or shortly after acute infection with SARS-CoV-2.
-
NewsCOVID-19 viral fragments shown to target and kill specific immune cells
New research shows that after the body’s defenses kill the virus behind COVID-19, leftover digested chunks of SARS-CoV-2 spike protein can target specific immune cells based on their shape. It could explain why certain populations of cells that detect and fight infection are depleted in patients with severe COVID-19.
-
NewsStudy cites link between mental health and long COVID in older women
Older women who have a history of both depression and anxiety had a 78% higher risk of developing long COVID after a SARS-CoV-2 infection, report researchers. Infection rates were not higher; only their risk of complications increased.
-
NewsLong COVID brain fog far more common in US than India, other nations
Patients with long COVID-19 in the U.S. report far higher rates of brain fog, depression and cognitive symptoms than patients in countries such as India and Nigeria, according to a large international study.
-
NewsScientists develop novel live-attenuated vaccine that blocks coronavirus transmission with a single intranasal dose
A research team at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has developed a novel live-attenuated vaccine candidate, cb1, capable of generating broad immunity against a wide range of beta-coronaviruses with a single intranasal dose. Source: NIAID-RML This colorized transmission electron microscope image shows ...
-
NewsDouble trouble: Tobacco use and Long COVID
Researchers investigating the relationship between Long Covid symptoms and smoking by tobacco type found that certain symptoms correlated with different forms of smoking.
-
CareersThe National Collection of Pathogenic Viruses (NCPV): a critical resource for virology and public health
It’s now 25 years since the National Collection of Pathogenic Viruses (NCPV) was founded as a dedicated, secure, and relevant national virus repository for the UK. Jane Burton, Teresa Ramalho and Tilly Maybery explore how the collection has evolved - and is tackling future global health concerns.
-
NewsEngineered nanobodies improved respiratory defenses in preclinical study
Engineered nanobodies improved protection against multiple viruses by bolstering respiratory mucus. The bispecific design of the nanobodies works against viruses, like influenza, which can normally evade mucosal defenses.
-
NewsHidden mpox exposure detected in healthy Nigerian adults, revealing under-recognized transmission
The mpox virus appears to be circulating silently in parts of Nigeria, in many cases without the symptoms typically associated with the disease, according to new research.
-
NewsPregnant women hospitalized for COVID-19, and their newborns, have higher complication risk
When hospitalized for COVID-19, pregnant women — and their eventual newborn children — have a higher risk of complications. Research revealed that pregnant women were nearly 3.5 times more likely than non-pregnant women to require respiratory support when hospitalized for COVID-19.